CC
Chemours Co
$17.81
+0.42 (+2.42%)
At close · Jul 10
Market Cap
$2.68B
Shares
150,377,709
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$5.81B
+0.4%
FY2025
Net Income
-$386M
-548.8%
FY2025
Gross Margin
15.53%
-4.4pp
FY2025
Diluted EPS
-$2.57
-550.9%
FY2025
Operating Cash Flow
$264M
+141.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $5.82B | $5.81B | $5.78B | $6.03B | $6.79B | $6.35B | $4.97B | $5.53B | $6.64B | $6.18B | $5.4B | $5.72B | |
| — | — | — | — | — | — | — | -$208M | -$195M | -$215M | -$213M | — | |
| $4.94B | $4.91B | $4.63B | $4.72B | $5.18B | $4.96B | $3.9B | $4.46B | $4.67B | $4.43B | $4.29B | $4.76B | |
| $878M | $902M | $1.15B | $1.31B | $1.62B | $1.38B | $1.07B | $1.06B | $1.97B | $1.75B | $1.11B | $955M | |
| — | 15.53% | 19.91% | 21.67% | 23.79% | 21.77% | 21.47% | 19.24% | 29.69% | 28.37% | 20.56% | 16.7% | |
| $107M | $108M | $109M | $108M | $118M | $107M | $93M | $80M | $82M | $80M | $80M | $97M | |
| $823M | $799M | $585M | $1.29B | $710M | $592M | $527M | $548M | $657M | $602M | $934M | $632M | |
| — | $1M | $1M | — | — | — | — | — | — | — | — | — | |
| $331M | $340M | $301M | $307M | $291M | $317M | $320M | $311M | $284M | $273M | $284M | $267M | |
| — | — | — | — | — | $12M | $20M | — | $14M | $24M | $4M | $135M | |
| $969M | $966M | $810M | $1.55B | $844M | $705M | $700M | $715M | $788M | $739M | $1.18B | — | |
| $926M | — | — | — | — | — | — | — | — | — | — | $1.09B | |
| $272M | $269M | $264M | $208M | $163M | $185M | $210M | $208M | $195M | $215M | $213M | $132M | |
| $43M | $26M | $8M | $91M | $70M | $163M | $21M | -$293M | $162M | $79M | $247M | — | |
| $35M | $35M | $43M | $45M | $55M | $43M | $23M | $29M | $43M | $33M | $29M | $22M | |
| -$299M | -$277M | $127M | -$318M | $741M | $676M | $179M | -$124M | $1.16B | $912M | -$11M | -$188M | |
| $98M | $109M | $41M | -$81M | $163M | $68M | -$40M | -$72M | $159M | $165M | -$18M | -$98M | |
| -$397M | -$386M | $86M | -$238M | $578M | $608M | $219M | -$52M | $995M | $746M | $7M | -$90M | |
| — | -6.65% | 1.49% | -3.95% | 8.51% | 9.58% | 4.41% | -0.94% | 14.99% | 12.07% | 0.13% | -1.57% | |
| — | $1M | $1M | -$1M | — | — | $0 | $0 | $1M | $1M | $0 | $0 | |
| -$309M | -$263M | -$7M | -$169M | $599M | $554M | $258M | $163M | $873M | $881M | -$34M | -$334M | |
| USD/shares | — | -$2.57 | $0.58 | -$1.60 | $3.72 | $3.69 | $1.33 | -$0.32 | $5.62 | $4.04 | $0.04 | -$0.50 |
| USD/shares | — | -$2.57 | $0.57 | -$1.60 | $3.65 | $3.60 | $1.32 | -$0.32 | $5.45 | $3.91 | $0.04 | -$0.50 |
| shares | — | 150.24M | 149.49M | 148.91M | 155.36M | 164.94M | 164.68M | 164.82M | 176.97M | 184.84M | 181.62M | 180.99M |
| shares | — | 150.24M | 150.17M | 148.91M | 158.3M | 168.7M | 166.35M | 164.82M | 182.57M | 190.98M | 183.42M | 180.99M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2015–FY2025: $1.95B in buybacks, $1.32B in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
1.07×
Specialty Chemicals median 1.96×
EV/EBIT
—
Specialty Chemicals median 28.61×
P/E (TTM)
—
Specialty Chemicals median 21.30×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| All Segments | $5,758,000,000 | $5,728,000,000 | — | — | — | — | — | — |
| Titanium Technologies | $2,429,000,000 | $2,572,000,000 | $2,680,000,000 | $3,380,000,000 | $3,355,000,000 | $2,402,000,000 | $2,345,000,000 | $3,174,000,000 |
| Thermal and Specialized Solutions | $2,066,000,000 | $1,830,000,000 | $1,851,000,000 | $1,702,000,000 | $1,257,000,000 | $1,105,000,000 | $1,318,000,000 | $1,497,000,000 |
| Advanced Performance Materials | $1,263,000,000 | $1,326,000,000 | $1,462,000,000 | $1,633,000,000 | $1,397,000,000 | $1,104,000,000 | $1,330,000,000 | $1,365,000,000 |
| Other Non-Reportable Segment | $50,000,000 | $54,000,000 | — | — | — | — | — | — |
| Chemical Solutions | — | — | — | — | — | — | $533,000,000 | $602,000,000 |
| All Other Segments | — | — | $85,000,000 | $116,000,000 | $336,000,000 | $358,000,000 | — | — |
By Geography (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| North America | $2,654,000,000 | $2,589,000,000 | $2,745,000,000 | $2,984,000,000 | $2,317,000,000 | $1,914,000,000 | $2,144,000,000 | $2,378,000,000 |
| Asia Pacific | $1,243,000,000 | $1,386,000,000 | $1,462,000,000 | $1,787,000,000 | $1,827,000,000 | $1,384,000,000 | $1,543,000,000 | $1,720,000,000 |
| EMEA | $1,163,000,000 | $1,138,000,000 | $1,197,000,000 | $1,315,000,000 | $1,412,000,000 | $1,086,000,000 | $1,163,000,000 | $1,685,000,000 |
| Latin America | $748,000,000 | $669,000,000 | $674,000,000 | $745,000,000 | $789,000,000 | $585,000,000 | $676,000,000 | $855,000,000 |
By Product & Service (USD)
| Component | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|
| SPS Capstone | $88,000,000 | $97,000,000 | $104,000,000 | — | — | — |
| Fluorochemicals | — | — | — | $1,318,000,000 | $1,497,000,000 | $1,378,000,000 |
| Fluoropolymers | — | — | — | $1,330,000,000 | $1,365,000,000 | $1,276,000,000 |
| Mining Solutions | — | — | — | $268,000,000 | $289,000,000 | $261,000,000 |
| Performance Chemicals and Intermediates | — | — | — | $265,000,000 | $313,000,000 | $306,000,000 |
| Titanium Dioxide and Other Minerals | — | — | — | $2,345,000,000 | $3,174,000,000 | $2,958,000,000 |
Key facts
CIK
1627223
CUSIP
163851108
13F (30d)
44 filings
24 filers
Visit website
Investor relations